Director Omnibus Decision – 25 IPRsMay 7, 2026
Notice of Decisions on Institution — 2026-05-07
Patent Trial and Appeal Board
Total Proceedings
25
in this notice
Total Denied
12
discretionary + merits
Total Instituted
7
trial granted
Grant Rate
37%
63% denial rate
Trial Instituted· 7 proceedings
IPR2026-00065IPR2026-00146IPR2026-00150IPR2026-00122IPR2026-00147PGR2026-00013IPR2026-00123
Discretionary Denial· 7 proceedings
IPR2026-00211IPR2026-00156IPR2026-00208IPR2026-00210IPR2026-00206IPR2026-00209IPR2026-00207
Institution Denied· 5 proceedings
IPR2026-00114IPR2026-00118IPR2026-00149IPR2026-00117IPR2026-00119
Referred for merits review· 6 proceedings
IPR2026-00140IPR2026-00191IPR2026-00193IPR2026-00175IPR2026-00192IPR2026-00195
Note
The USPTO Director issued an omnibus institution notice covering multiple proceedings. Written opinions may follow for selected cases. After review of discretionary considerations, 6 proceedings will be reviewed for merits and non-discretionary considerations; their institution decisions will come in a later notice.
New to PTAB and post-grant? Start with IPR vs. PGR: Inter Partes Review and Post-Grant Review Compared
- PTAB Director Review · Oct. 8, 2026Notice of Decisions on Institution — 2026-10-08
- PTAB Director Review · Sept. 24, 2026Biocon Biologics Limited et al. v. Regeneron Pharmaceuticals, Inc.
- PTAB Director Review · Sept. 23, 2026Notice of Decisions on Institution — 2026-09-23
- PTAB Director Review · Sept. 23, 2026Nearmap US, Inc. v. Eagle View Technologies, Inc.
- PTAB Director Review · Aug. 25, 2026Aesthetic Management Partners, LLC and Aesthetic Management Partners, Inc. v. HydraFacial LLC